RLMD - Relmada Therapeutics GAAP EPS of -$0.72 beats by $0.15
2024-05-09 12:41:10 ET
More on Relmada Therapeutics
- Relmada Therapeutics: Run Up Into Results May Resume Following This Drop
- Relmada Therapeutics, Inc. (RLMD) Q4 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Relmada Therapeutics
- Historical earnings data for Relmada Therapeutics
- Financial information for Relmada Therapeutics